Proposed pact highlights genetic diagnostics in cancer treatment
Roche Holding AG agreed to pay $1.03 billion for up to a 56.3% stake in Foundation Medicine Inc. FMI, +3.37% in a collaboration that underscores the growing importance of genetic diagnostics in the treatment and development of drugs for cancer.
04:49 UBS sees tough markets ahead as third-quarter profit drops15
11:33 Twitter layoffs come atop surprisingly strong profit18
20:54 Groupon Buys LivingSocial, a Rival Once Valued at $6 Billion15
21:06 Apple's Q4 2016 results: Better than expected with 45.5 million iPhones sold, but revenue continues to slide18